OTC Drug Market Report

Global and Regional OTC Drug Market Details Research Report 2021-2026

  • POSTDATE：Jun 25, 2021
  • PAGES：184
  • REPORT CODE：GMM718253
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global OTC Drug Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive OTC Drug market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global OTC Drug market.

    By Player:

    • Eli Lilly

    • Euradite

    • Bristol Myers Squibb

    • Chr Hansen

    • Johnson&Johnson

    • CoLucid

    • Sanofi

    • GlaxoSmithKline (GSK)

    • BioGaia

    • DSM

    • Friggs

    • AstraZeneca

    • Eisai

    • Pfizer

    • Daiichi Sankyo

    • Cipla

    • Herbalife

    • Bukwang Pharmaceutica

    • Bayer HealthCare

    By Type:

    • Class A

    • Class B

    By End-User:

    • Hospital

    • Clinic

    • Household

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 OTC Drug Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global OTC Drug Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global OTC Drug Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global OTC Drug Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global OTC Drug Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers OTC Drug Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Eli Lilly

      • 3.1.1 Eli Lilly - Company Business Overview

      • 3.1.2 Eli Lilly - Company Financial Performance

      • 3.1.3 Eli Lilly - Company Financial Performance of OTC Drug

      • 3.1.4 OTC Drug Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Euradite

      • 3.2.1 Euradite - Company Business Overview

      • 3.2.2 Euradite - Company Financial Performance

      • 3.2.3 Euradite - Company Financial Performance of OTC Drug

      • 3.2.4 OTC Drug Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Bristol Myers Squibb

      • 3.3.1 Bristol Myers Squibb - Company Business Overview

      • 3.3.2 Bristol Myers Squibb - Company Financial Performance

      • 3.3.3 Bristol Myers Squibb - Company Financial Performance of OTC Drug

      • 3.3.4 OTC Drug Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Chr Hansen

      • 3.4.1 Chr Hansen - Company Business Overview

      • 3.4.2 Chr Hansen - Company Financial Performance

      • 3.4.3 Chr Hansen - Company Financial Performance of OTC Drug

      • 3.4.4 OTC Drug Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Johnson&Johnson

      • 3.5.1 Johnson&Johnson - Company Business Overview

      • 3.5.2 Johnson&Johnson - Company Financial Performance

      • 3.5.3 Johnson&Johnson - Company Financial Performance of OTC Drug

      • 3.5.4 OTC Drug Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 CoLucid

      • 3.6.1 CoLucid - Company Business Overview

      • 3.6.2 CoLucid - Company Financial Performance

      • 3.6.3 CoLucid - Company Financial Performance of OTC Drug

      • 3.6.4 OTC Drug Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Sanofi

      • 3.7.1 Sanofi - Company Business Overview

      • 3.7.2 Sanofi - Company Financial Performance

      • 3.7.3 Sanofi - Company Financial Performance of OTC Drug

      • 3.7.4 OTC Drug Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 GlaxoSmithKline (GSK)

      • 3.8.1 GlaxoSmithKline (GSK) - Company Business Overview

      • 3.8.2 GlaxoSmithKline (GSK) - Company Financial Performance

      • 3.8.3 GlaxoSmithKline (GSK) - Company Financial Performance of OTC Drug

      • 3.8.4 OTC Drug Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 BioGaia

      • 3.9.1 BioGaia - Company Business Overview

      • 3.9.2 BioGaia - Company Financial Performance

      • 3.9.3 BioGaia - Company Financial Performance of OTC Drug

      • 3.9.4 OTC Drug Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 DSM

      • 3.10.1 DSM - Company Business Overview

      • 3.10.2 DSM - Company Financial Performance

      • 3.10.3 DSM - Company Financial Performance of OTC Drug

      • 3.10.4 OTC Drug Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Friggs

      • 3.11.1 Friggs - Company Business Overview

      • 3.11.2 Friggs - Company Financial Performance

      • 3.11.3 Friggs - Company Financial Performance of OTC Drug

      • 3.11.4 OTC Drug Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 AstraZeneca

      • 3.12.1 AstraZeneca - Company Business Overview

      • 3.12.2 AstraZeneca - Company Financial Performance

      • 3.12.3 AstraZeneca - Company Financial Performance of OTC Drug

      • 3.12.4 OTC Drug Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Eisai

      • 3.13.1 Eisai - Company Business Overview

      • 3.13.2 Eisai - Company Financial Performance

      • 3.13.3 Eisai - Company Financial Performance of OTC Drug

      • 3.13.4 OTC Drug Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Pfizer

      • 3.14.1 Pfizer - Company Business Overview

      • 3.14.2 Pfizer - Company Financial Performance

      • 3.14.3 Pfizer - Company Financial Performance of OTC Drug

      • 3.14.4 OTC Drug Product Benchmarking

      • 3.14.5 Strategic Initiatives

    • 3.15 Daiichi Sankyo

      • 3.15.1 Daiichi Sankyo - Company Business Overview

      • 3.15.2 Daiichi Sankyo - Company Financial Performance

      • 3.15.3 Daiichi Sankyo - Company Financial Performance of OTC Drug

      • 3.15.4 OTC Drug Product Benchmarking

      • 3.15.5 Strategic Initiatives

    • 3.16 Cipla

      • 3.16.1 Cipla - Company Business Overview

      • 3.16.2 Cipla - Company Financial Performance

      • 3.16.3 Cipla - Company Financial Performance of OTC Drug

      • 3.16.4 OTC Drug Product Benchmarking

      • 3.16.5 Strategic Initiatives

    • 3.17 Herbalife

      • 3.17.1 Herbalife - Company Business Overview

      • 3.17.2 Herbalife - Company Financial Performance

      • 3.17.3 Herbalife - Company Financial Performance of OTC Drug

      • 3.17.4 OTC Drug Product Benchmarking

      • 3.17.5 Strategic Initiatives

    • 3.18 Bukwang Pharmaceutica

      • 3.18.1 Bukwang Pharmaceutica - Company Business Overview

      • 3.18.2 Bukwang Pharmaceutica - Company Financial Performance

      • 3.18.3 Bukwang Pharmaceutica - Company Financial Performance of OTC Drug

      • 3.18.4 OTC Drug Product Benchmarking

      • 3.18.5 Strategic Initiatives

    • 3.19 Bayer HealthCare

      • 3.19.1 Bayer HealthCare - Company Business Overview

      • 3.19.2 Bayer HealthCare - Company Financial Performance

      • 3.19.3 Bayer HealthCare - Company Financial Performance of OTC Drug

      • 3.19.4 OTC Drug Product Benchmarking

      • 3.19.5 Strategic Initiatives

    4 Global OTC Drug Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global OTC Drug Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Class A 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Class B 2016-2021

    • 4.3 Global OTC Drug Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Class A 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Class B 2016-2021

    • 4.4 Global OTC Drug Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global OTC Drug Market Sales and Market Share by Types (Forecast)

    • 4.6 Global OTC Drug Market Price By Type from 2016 to 2026

    5 Global OTC Drug Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of OTC Drug

    • 5.2 Global OTC Drug Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Hospital 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Clinic 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Household 2016-2021

    • 5.3 Global OTC Drug Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Hospital 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Clinic 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Household 2016-2021

    • 5.4 Global OTC Drug Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global OTC Drug Market Sales and Market Share by Application (Forecast)

    6 Global OTC Drug Market Segment Analysis (Geography Level)

    • 6.1 Global OTC Drug Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global OTC Drug Market Sales and Market Share by Geography (Historical)

    • 6.3 Global OTC Drug Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global OTC Drug Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in OTC Drug Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in OTC Drug Market from 2016 to 2020

    7. North America OTC Drug Market Segment Analysis and Investment Attractiveness

    • 7.1 North America OTC Drug Market Segment by Countries

      • 7.1.1 North America OTC Drug Market Revenue Segment by Countries

      • 7.1.2 North America OTC Drug Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America OTC Drug Market Segment (Product Type Level)

    • 7.3 North America OTC Drug Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe OTC Drug Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe OTC Drug Market Segment by Countries

      • 8.1.1 Europe OTC Drug Market Revenue Segment by Countries

      • 8.1.2 Europe OTC Drug Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe OTC Drug Market Segment (Product Type Level)

    • 8.3 Europe OTC Drug Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia OTC Drug Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia OTC Drug Market Segment by Countries

      • 9.1.1 Asia OTC Drug Market Revenue Segment by Countries

      • 9.1.2 Asia OTC Drug Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia OTC Drug Market Segment (Product Type Level)

    • 9.3 Asia OTC Drug Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America OTC Drug Market Segment Analysis and Investment Attractiveness

    • 10.1 South America OTC Drug Market Segment by Countries

      • 10.1.1 South America OTC Drug Market Revenue Segment by Countries

      • 10.1.2 South America OTC Drug Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America OTC Drug Market Segment (Product Type Level)

    • 10.3 South America OTC Drug Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East OTC Drug Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East OTC Drug Market Segment by Countries

      • 11.1.1 Middle East OTC Drug Market Revenue Segment by Countries

      • 11.1.2 Middle East OTC Drug Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East OTC Drug Market Segment (Product Type Level)

    • 11.3 Middle East OTC Drug Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa OTC Drug Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa OTC Drug Market Segment by Countries

      • 12.1.1 Africa OTC Drug Market Revenue Segment by Countries

      • 12.1.2 Africa OTC Drug Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa OTC Drug Market Segment (Product Type Level)

    • 12.3 Africa OTC Drug Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania OTC Drug Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania OTC Drug Market Segment by Countries

      • 13.1.1 Oceania OTC Drug Market Revenue Segment by Countries

      • 13.1.2 Oceania OTC Drug Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania OTC Drug Market Segment (Product Type Level)

    • 13.3 Oceania OTC Drug Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 OTC Drug Production Analysis

      • 14.2.1 Manufacturing Cost Structure of OTC Drug

      • 14.2.2 Manufacturing Process Analysis of OTC Drug

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of OTC Drug Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 OTC Drug Industry Market Status, Pre-COVID-19

      • 15.5.3 OTC Drug Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 OTC Drug Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure OTC Drug Product Picture

    • Table OTC Drug Product Definition

    • Table Study Scope by Types

    • Figure Global OTC Drug Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global OTC Drug Market Value by Application (2016 - 2026)

    • Figure Global OTC Drug Market Size and Growth Rate from 2016 to 2026

    • Table Global OTC Drug Production Capacity by Manufacturers (2016-2021)

    • Table Global OTC Drug Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global OTC Drug Revenue by Manufacturers (2016-2021)

    • Table Global OTC Drug Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers OTC Drug Plant Distribution and Sales Country

    • Table Eli Lilly - Company Business Overview

    • Figure Eli Lilly Total Revenue from 2018 to 2020

    • Table Eli Lilly Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eli Lilly Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table OTC Drug Product Benchmarking

    • Table Euradite - Company Business Overview

    • Figure Euradite Total Revenue from 2018 to 2020

    • Table Euradite Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Euradite Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Euradite

    • Table OTC Drug Product Benchmarking

    • Table Bristol Myers Squibb - Company Business Overview

    • Figure Bristol Myers Squibb Total Revenue from 2018 to 2020

    • Table Bristol Myers Squibb Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bristol Myers Squibb Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Bristol Myers Squibb

    • Table OTC Drug Product Benchmarking

    • Table Chr Hansen - Company Business Overview

    • Figure Chr Hansen Total Revenue from 2018 to 2020

    • Table Chr Hansen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Chr Hansen Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Chr Hansen

    • Table OTC Drug Product Benchmarking

    • Table Johnson&Johnson - Company Business Overview

    • Figure Johnson&Johnson Total Revenue from 2018 to 2020

    • Table Johnson&Johnson Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Johnson&Johnson Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Johnson&Johnson

    • Table OTC Drug Product Benchmarking

    • Table CoLucid - Company Business Overview

    • Figure CoLucid Total Revenue from 2018 to 2020

    • Table CoLucid Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure CoLucid Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of CoLucid

    • Table OTC Drug Product Benchmarking

    • Table Sanofi - Company Business Overview

    • Figure Sanofi Total Revenue from 2018 to 2020

    • Table Sanofi Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sanofi Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table OTC Drug Product Benchmarking

    • Table GlaxoSmithKline (GSK) - Company Business Overview

    • Figure GlaxoSmithKline (GSK) Total Revenue from 2018 to 2020

    • Table GlaxoSmithKline (GSK) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GlaxoSmithKline (GSK) Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline (GSK)

    • Table OTC Drug Product Benchmarking

    • Table BioGaia - Company Business Overview

    • Figure BioGaia Total Revenue from 2018 to 2020

    • Table BioGaia Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure BioGaia Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of BioGaia

    • Table OTC Drug Product Benchmarking

    • Table DSM - Company Business Overview

    • Figure DSM Total Revenue from 2018 to 2020

    • Table DSM Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure DSM Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of DSM

    • Table OTC Drug Product Benchmarking

    • Table Friggs - Company Business Overview

    • Figure Friggs Total Revenue from 2018 to 2020

    • Table Friggs Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Friggs Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Friggs

    • Table OTC Drug Product Benchmarking

    • Table AstraZeneca - Company Business Overview

    • Figure AstraZeneca Total Revenue from 2018 to 2020

    • Table AstraZeneca Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure AstraZeneca Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table OTC Drug Product Benchmarking

    • Table Eisai - Company Business Overview

    • Figure Eisai Total Revenue from 2018 to 2020

    • Table Eisai Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eisai Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Eisai

    • Table OTC Drug Product Benchmarking

    • Table Pfizer - Company Business Overview

    • Figure Pfizer Total Revenue from 2018 to 2020

    • Table Pfizer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pfizer Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table OTC Drug Product Benchmarking

    • Table Daiichi Sankyo - Company Business Overview

    • Figure Daiichi Sankyo Total Revenue from 2018 to 2020

    • Table Daiichi Sankyo Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Daiichi Sankyo Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table OTC Drug Product Benchmarking

    • Table Cipla - Company Business Overview

    • Figure Cipla Total Revenue from 2018 to 2020

    • Table Cipla Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Cipla Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Cipla

    • Table OTC Drug Product Benchmarking

    • Table Herbalife - Company Business Overview

    • Figure Herbalife Total Revenue from 2018 to 2020

    • Table Herbalife Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Herbalife Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Herbalife

    • Table OTC Drug Product Benchmarking

    • Table Bukwang Pharmaceutica - Company Business Overview

    • Figure Bukwang Pharmaceutica Total Revenue from 2018 to 2020

    • Table Bukwang Pharmaceutica Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bukwang Pharmaceutica Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Bukwang Pharmaceutica

    • Table OTC Drug Product Benchmarking

    • Table Bayer HealthCare - Company Business Overview

    • Figure Bayer HealthCare Total Revenue from 2018 to 2020

    • Table Bayer HealthCare Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bayer HealthCare Sales and Growth Rate Analysis of OTC Drug

    • Figure Revenue and Market Share Analysis of Bayer HealthCare

    • Table OTC Drug Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global OTC Drug Market Revenue by Types (Historical)

    • Table Global OTC Drug Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Class A 2016-2021

    • Figure Global Revenue and Growth Rate of Class B 2016-2021

    • Table Global OTC Drug Market Sales by Types (Historical)

    • Table Global OTC Drug Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Class A 2016-2021

    • Figure Global Sales and Growth Rate of Class B 2016-2021

    • Table Global OTC Drug Market Revenue by Types (Forecast)

    • Table Global OTC Drug Market Revenue Market Share by Types (Forecast)

    • Table Global OTC Drug Market Sales by Types (Forecast)

    • Table Global OTC Drug Market Sales Market Share by Types (Forecast)

    • Figure Global OTC Drug Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for OTC Drug

    • Table Global OTC Drug Market Revenue by Application (Historical)

    • Table Global OTC Drug Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Hospital 2016-2021

    • Figure Global Revenue and Growth Rate of Clinic 2016-2021

    • Figure Global Revenue and Growth Rate of Household 2016-2021

    • Table Global OTC Drug Market Sales by Application (Historical)

    • Table Global OTC Drug Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Hospital 2016-2021

    • Figure Global Sales and Growth Rate of Clinic 2016-2021

    • Figure Global Sales and Growth Rate of Household 2016-2021

    • Table Global OTC Drug Market Revenue by Application (Forecast)

    • Table Global OTC Drug Market Revenue Market Share by Application (Forecast)

    • Table Global OTC Drug Market Sales by Application (Forecast)

    • Table Global OTC Drug Market Sales Market Share by Application (Forecast)

    • Table Global OTC Drug Market Revenue by Geography (Historical)

    • Table Global OTC Drug Market Revenue Market Share by Geography (Historical)

    • Figure Global OTC Drug Revenue Market Share by Geography in 2020

    • Table Global OTC Drug Market Sales by Geography (Historical)

    • Table Global OTC Drug Market Sales Market Share by Geography (Historical)

    • Figure Global OTC Drug Sales Market Share by Geography in 2020

    • Table Global OTC Drug Market Revenue by Geography (Forecast)

    • Table Global OTC Drug Market Revenue Market Share by Geography (Forecast)

    • Table Global OTC Drug Market Sales by Geography (Forecast)

    • Table Global OTC Drug Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America OTC Drug Revenue by Countries from 2016 to 2026

    • Table North America OTC Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure North America OTC Drug Revenue Market Share by Major Countries in 2020

    • Table North America OTC Drug Sales by Countries from 2016 to 2026

    • Table North America OTC Drug Sales Market Share by Countries from 2016 to 2026

    • Figure North America OTC Drug Sales Market Share by Major Countries in 2020

    • Figure USA OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure USA OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Canada OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Table North America OTC Drug Sales by Types from 2016 to 2026

    • Table North America OTC Drug Sales Market Share by Types from 2016 to 2026

    • Table North America OTC Drug Value by Types from 2016 to 2026

    • Table North America OTC Drug Value Market Share by Types from 2016 to 2026

    • Table North America OTC Drug Sales by Application from 2016 to 2026

    • Table North America OTC Drug Sales Market Share by Application from 2016 to 2026

    • Table North America OTC Drug Value by Application from 2016 to 2026

    • Table North America OTC Drug Value Market Share by Application from 2016 to 2026

    • Table Europe OTC Drug Revenue by Countries from 2016 to 2026

    • Table Europe OTC Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe OTC Drug Revenue Market Share by Major Countries in 2020

    • Table Europe OTC Drug Sales by Countries from 2016 to 2026

    • Table Europe OTC Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Europe OTC Drug Sales Market Share by Major Countries in 2020

    • Figure Germany OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Germany OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure France OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure France OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Italy OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Russia OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Spain OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Poland OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Austria OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Europe OTC Drug Sales by Types from 2016 to 2026

    • Table Europe OTC Drug Sales Market Share by Types from 2016 to 2026

    • Table Europe OTC Drug Value by Types from 2016 to 2026

    • Table Europe OTC Drug Value Market Share by Types from 2016 to 2026

    • Table Europe OTC Drug Sales by Application from 2016 to 2026

    • Table Europe OTC Drug Sales Market Share by Application from 2016 to 2026

    • Table Europe OTC Drug Value by Application from 2016 to 2026

    • Table Europe OTC Drug Value Market Share by Application from 2016 to 2026

    • Table Asia OTC Drug Revenue by Countries from 2016 to 2026

    • Table Asia OTC Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia OTC Drug Revenue Market Share by Major Countries in 2020

    • Table Asia OTC Drug Sales by Countries from 2016 to 2026

    • Table Asia OTC Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Asia OTC Drug Sales Market Share by Major Countries in 2020

    • Figure China OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure China OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Japan OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure India OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure India OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Asia OTC Drug Sales by Types from 2016 to 2026

    • Table Asia OTC Drug Sales Market Share by Types from 2016 to 2026

    • Table Asia OTC Drug Value by Types from 2016 to 2026

    • Table Asia OTC Drug Value Market Share by Types from 2016 to 2026

    • Table Asia OTC Drug Sales by Application from 2016 to 2026

    • Table Asia OTC Drug Sales Market Share by Application from 2016 to 2026

    • Table Asia OTC Drug Value by Application from 2016 to 2026

    • Table Asia OTC Drug Value Market Share by Application from 2016 to 2026

    • Table South America OTC Drug Revenue by Countries from 2016 to 2026

    • Table South America OTC Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure South America OTC Drug Revenue Market Share by Major Countries in 2020

    • Table South America OTC Drug Sales by Countries from 2016 to 2026

    • Table South America OTC Drug Sales Market Share by Countries from 2016 to 2026

    • Figure South America OTC Drug Sales Market Share by Major Countries in 2020

    • Figure Brazil OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Chile OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Table South America OTC Drug Sales by Types from 2016 to 2026

    • Table South America OTC Drug Sales Market Share by Types from 2016 to 2026

    • Table South America OTC Drug Value by Types from 2016 to 2026

    • Table South America OTC Drug Value Market Share by Types from 2016 to 2026

    • Table South America OTC Drug Sales by Application from 2016 to 2026

    • Table South America OTC Drug Sales Market Share by Application from 2016 to 2026

    • Table South America OTC Drug Value by Application from 2016 to 2026

    • Table South America OTC Drug Value Market Share by Application from 2016 to 2026

    • Table Middle East OTC Drug Revenue by Countries from 2016 to 2026

    • Table Middle East OTC Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East OTC Drug Revenue Market Share by Major Countries in 2020

    • Table Middle East OTC Drug Sales by Countries from 2016 to 2026

    • Table Middle East OTC Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East OTC Drug Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East OTC Drug Sales by Types from 2016 to 2026

    • Table Middle East OTC Drug Sales Market Share by Types from 2016 to 2026

    • Table Middle East OTC Drug Value by Types from 2016 to 2026

    • Table Middle East OTC Drug Value Market Share by Types from 2016 to 2026

    • Table Middle East OTC Drug Sales by Application from 2016 to 2026

    • Table Middle East OTC Drug Sales Market Share by Application from 2016 to 2026

    • Table Middle East OTC Drug Value by Application from 2016 to 2026

    • Table Middle East OTC Drug Value Market Share by Application from 2016 to 2026

    • Table Africa OTC Drug Revenue by Countries from 2016 to 2026

    • Table Africa OTC Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa OTC Drug Revenue Market Share by Major Countries in 2020

    • Table Africa OTC Drug Sales by Countries from 2016 to 2026

    • Table Africa OTC Drug Sales Market Share by Countries from 2016 to 2026

      • Figure Africa OTC Drug Sales Market Share by Major Countries in 2020

    • Figure Nigeria OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Africa OTC Drug Sales by Types from 2016 to 2026

    • Table Africa OTC Drug Sales Market Share by Types from 2016 to 2026

    • Table Africa OTC Drug Value by Types from 2016 to 2026

    • Table Africa OTC Drug Value Market Share by Types from 2016 to 2026

    • Table Africa OTC Drug Sales by Application from 2016 to 2026

    • Table Africa OTC Drug Sales Market Share by Application from 2016 to 2026

    • Table Africa OTC Drug Value by Application from 2016 to 2026

    • Table Africa OTC Drug Value Market Share by Application from 2016 to 2026

    • Table Oceania OTC Drug Revenue by Countries from 2016 to 2026

    • Table Oceania OTC Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania OTC Drug Revenue Market Share by Major Countries in 2020

    • Table Oceania OTC Drug Sales by Countries from 2016 to 2026

    • Table Oceania OTC Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania OTC Drug Sales Market Share by Major Countries in 2020

    • Figure Australia OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Australia OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others OTC Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania OTC Drug Sales by Types from 2016 to 2026

    • Table Oceania OTC Drug Sales Market Share by Types from 2016 to 2026

    • Table Oceania OTC Drug Value by Types from 2016 to 2026

    • Table Oceania OTC Drug Value Market Share by Types from 2016 to 2026

    • Table Oceania OTC Drug Sales by Application from 2016 to 2026

    • Table Oceania OTC Drug Sales Market Share by Application from 2016 to 2026

    • Table Oceania OTC Drug Value by Application from 2016 to 2026

    • Table Oceania OTC Drug Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of OTC Drug

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of OTC Drug with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US